News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
129,530 Results
Type
Article (17856)
Company Profile (124)
Press Release (111546)
Multimedia
Podcasts (268)
Webinars (24)
Section
Business (43360)
Career Advice (853)
Deals (6636)
Drug Delivery (148)
Drug Development (16467)
Employer Resources (149)
FDA (2573)
Job Trends (3573)
News (61765)
Policy (5431)
Tag
2025 Best Places to Work (10)
2026 Best Places to Work (14)
2027 BioCapital Standard (1)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Standard (2)
2027 Genetown Elite (1)
2027 Genetown Standard (2)
2027 NextGen (4)
2027 Pharm Country Digital (3)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (4)
40 Under 40 (4)
Academia (573)
Academic (1)
Accelerated approval (23)
ADA (12)
Adcomms (17)
Allergies (46)
Alliances (10504)
ALS (56)
Alzheimer's disease (605)
Antibody-drug conjugate (ADC) (209)
Approvals (2415)
Artificial intelligence (393)
ASCO (93)
Autoimmune disease (151)
Automation (21)
Bankruptcy (79)
Belgium (12)
Best Places to Work (1759)
BIO (84)
Biologics (36)
BIOSECURE Act (16)
Biosimilars (83)
BioSpace Insights (262)
Biotechnology (71)
Bispecific (12)
Bladder cancer (62)
Brain cancer (26)
Breast cancer (151)
Cancer (1641)
Cardiovascular disease (200)
Career advice (784)
Career pathing (46)
CAR-T (143)
CDC (32)
CDMO (165)
Celiac Disease (4)
Cell-line development (2)
Cell therapy (460)
Cervical cancer (6)
Clinical research (12966)
Collaboration (769)
Commercialization (17)
Company closure (8)
Compensation (213)
Complete response letters (28)
COVID-19 (1393)
CRISPR (55)
CRO (5)
C-suite (507)
Cystic fibrosis (35)
Data (2033)
Decentralized trials (3)
Denatured (113)
Depression (55)
Dermatology (19)
Diabetes (149)
Diagnostics (1218)
Digital health (6)
Diversity (11)
Diversity, equity & inclusion (41)
Drug discovery (205)
Drug pricing (98)
Drug shortages (13)
Duchenne muscular dystrophy (93)
Earnings (12385)
Editorial (59)
Employer branding (24)
Employer resources (125)
ESMO (93)
Events (22270)
Executive appointments (362)
Eye disease (7)
FDA (3294)
Fragile X (1)
Friedreich's ataxia (13)
Frontotemporal dementia (10)
Funding (818)
Gene editing (122)
Generative AI (49)
Gene therapy (362)
GLP-1 (483)
Government (1224)
Grass and pollen (2)
Guidances (59)
Healthcare (2402)
Hematology (43)
HIV (22)
Huntington's disease (32)
Idiopathic pulmonary fibrosis (4)
IgA nephropathy (43)
Immunology and inflammation (161)
Immuno-oncology (66)
Indications (36)
Infectious disease (1475)
Inflammatory bowel disease (58)
Inflation Reduction Act (11)
Influenza (22)
Intellectual property (73)
Interviews (145)
IPO (2557)
IRA (28)
Job creations (1635)
Job search strategy (660)
JPM (61)
Kidney cancer (2)
Kidney disease (36)
Labor market (146)
Layoffs (360)
Leadership (34)
Legal (1256)
Licensing (34)
Liver cancer (31)
Longevity (21)
Lung cancer (287)
Lung diease (10)
Lymphoma (104)
Machine learning (35)
Management (37)
Manufacturing (583)
Marketing (11)
MASH (62)
Medical affairs (1)
Medical device (1195)
Medtech (1253)
Mergers & acquisitions (4372)
Metabolic disorders (538)
Middle East (2)
mRNA (203)
Multiple sclerosis (56)
Multispecific (3)
NASH (8)
Netherlands (8)
Neurodegenerative disease (217)
Neuropsychiatric disorders (41)
Neuroscience (1124)
Neurotech (1)
NextGen: Class of 2026 (1468)
Non-profit (475)
Now hiring (94)
Obesity (297)
Opinion (215)
Ovarian cancer (50)
Pain (67)
Pancreatic cancer (72)
Parkinson's disease (119)
Partnered (37)
Patents (162)
Patient advocacy (3)
Patient recruitment (180)
Patient selection (20)
Peanut (7)
People (13448)
Peptides (8)
Pharmaceutical (14)
Pharmacy benefit managers (11)
Phase 1 (4445)
Phase 2 (6025)
Phase 3 (4642)
Pipeline (2826)
Policy (242)
Postmarket research (287)
Preclinical (1863)
Press Release (24)
Prostate cancer (53)
Psychedelics (60)
Radioligand (2)
Radiopharmaceuticals (89)
Rare diseases (473)
Real estate (1610)
Recruiting (57)
Regenerative medicine (8)
Regulatory (4564)
Reports (69)
Research institute (529)
Resumes & cover letters (122)
Rett syndrome (8)
RNA editing (24)
RSV (9)
Saudi Arabia (1)
Schizophrenia (51)
Series A (191)
Series B (126)
Series C (1)
Service/supplier (2)
Sickle cell disease (33)
Special edition (37)
Spinal muscular atrophy (28)
Sponsored (33)
Startups (1441)
State (1)
Stem cells (3)
Stomach cancer (5)
Substance use disorders (6)
Supply chain (42)
Switzerland (5)
Tariffs (35)
Tax incentives (2)
The Weekly (152)
Vaccines (619)
Venture capital (138)
Weight loss (215)
Wet AMD (3)
Women's health (46)
Women in leadership (2)
Worklife (22)
Date
Today (29)
Last 7 days (184)
Last 30 days (800)
Last 365 days (6889)
2026 (6368)
2025 (6254)
2024 (7483)
2023 (8182)
2022 (10888)
2021 (10959)
2020 (8745)
2019 (6387)
2018 (4716)
2017 (6265)
2016 (6479)
2015 (7222)
2014 (5191)
2013 (3929)
2012 (4283)
2011 (4294)
2010 (4108)
Location
Africa (376)
Alabama (19)
Alaska (1)
Arizona (54)
Arkansas (2)
Asia (10781)
Australia (1428)
California (3679)
Canada (618)
China (550)
Colorado (130)
Connecticut (124)
Delaware (104)
Europe (18471)
Florida (564)
Georgia (56)
Hawaii (2)
Idaho (17)
Illinois (203)
India (37)
Indiana (67)
Iowa (6)
Japan (167)
Kansas (25)
Kentucky (7)
Louisiana (12)
Maine (2)
Maryland (374)
Massachusetts (2267)
Michigan (40)
Minnesota (123)
Mississippi (1)
Missouri (45)
Montana (4)
Nebraska (4)
Nevada (111)
New Hampshire (13)
New Jersey (718)
New Mexico (16)
New York (735)
North Carolina (503)
North Dakota (3)
Northern California (1941)
Ohio (91)
Oklahoma (12)
Oregon (10)
Pennsylvania (738)
Puerto Rico (13)
Rhode Island (9)
South America (394)
South Carolina (5)
South Dakota (1)
Southern California (1299)
Tennessee (30)
Texas (615)
United States (11147)
Utah (90)
Virginia (44)
Washington D.C. (19)
Washington State (218)
West Virginia (1)
Wisconsin (27)
129,530 Results for "landmark bio".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
CancerVax Successfully Kills Cancer Cells in Landmark Test
November 17, 2026
·
6 min read
Press Releases
Parse Biosciences and bit.bio Announce Landmark Alliance
May 27, 2026
·
3 min read
Press Releases
Caris Launches Landmark Study to Challenge Fragmented Testing in Myeloid Malignancies
November 11, 2026
·
7 min read
Press Releases
Landmark Medicines Advances Proprietary Nasal GLP-1 Platform Towards Human Evaluation
September 29, 2026
·
2 min read
Press Releases
Lucid Diagnostics Announces Publication of Landmark 12,000-Patient Real-World EsoGuard® Study
November 3, 2026
·
4 min read
Press Releases
Bio Preventive Medicine and Precision Diabetes Announce ADA Late-Breaking Presentation Highlighting DNlite™ in Landmark CREDENCE Trial
June 7, 2026
·
4 min read
Press Releases
Noetik Achieves First Milestone in Landmark GSK Collaboration
August 26, 2026
·
3 min read
Drug Development
Dren Bio lands $350M to push rare blood cancer therapy toward market
After Sanofi paid $600 million in cash to acquire Dren Bio’s bispecific last year, the biotech has secured a hefty financing to fund late-stage development and commercial preparations for its lead asset.
October 29, 2026
·
2 min read
·
Gabrielle Masson
Press Releases
Live from ESMO | Hengrui Debuts Exhibition Booth with Landmark Data Showcasing Pharma’s Emerging Innovation Power
October 25, 2026
·
8 min read
China
BIO pitches US plan to beat China in biotech ‘space race’
The seven proposals in the Bio Advance plan include easing clinical trial starts, boosting manufacturing and establishing a new White House office to coordinate the government’s biotech policy.
November 10, 2026
·
2 min read
·
Annalee Armstrong
1 of 12,953
Next